한글목차

리소자임 시장 규모는 2024년에 7,618만 달러로 평가되었고, 2025-2031년의 예측 기간에 CAGR 3.5%로 성장을 지속하여, 2031년까지 9,299만 달러에 달할 것으로 예측됩니다.

본 보고서는 리소팀의 국경 간 산업 발자국, 자본 배분 패턴, 지역 경제의 상호의존성, 공급망 재구축, 최근 관세 조정 및 국제적인 전략적 대응 조치에 대한 종합적인 평가를 제공합니다.

리소자임(일명: 무라미다제 또는 N-아세틸라미드글리코시다아제)은 세균 내 점액 다당류를 가수분해하는 알칼리성 효소입니다. 리소자임은 주로 세포벽 내 N-아세틸라민산과 N-아세틸글루코사민 사이의 β-1,4글리코사이드 결합을 절단하여 세포벽의 불용성 점액 다당류를 가용성 글리코펩티드로 분해합니다. 이로 인해 세포벽이 파열되고 박테리아가 용해됩니다. 또한 리소자임은 음전하를 띤 바이러스 단백질에 직접 결합하여 DNA, RNA, 아포단백질과 복합체를 형성하여 바이러스를 비활성화시킵니다. 원료의 출처에 따라 난백 유래 리소자임과 미생물 유래 리소자임으로 분류됩니다.

제품 유형별로는 난백 유형이 중요한 위치를 차지하고 있으며, 2031년에는 매출 점유율이 약 60%를 보일 것으로 예측됩니다. 난백 리소자임과 미생물 리소자임의 가격 차이가 크며, 이는 리소자임의 활성과 밀접한 관련이 있습니다.

리조팀의 주요 소비 지역은 아시아, 라틴아메리카, 유럽입니다. 2024년 현재 라틴아메리카가 세계 최대 소비 시장으로 부상했습니다.

리소자임의 세계적인 주요 제조업체로는 Bioseutica, Novozymes, Zhejiang Aegis Biotech, dsm-firmenich, and Greensnow Egg Products Development 등이 있습니다. 수익 측면에서는 2024년 세계 상위 3개사가 70% 이상 시장 점유율을 차지했습니다.

이 보고서는 리소자임 세계 시장에 대해 총 판매량, 매출액, 가격, 주요 기업의 시장 점유율 및 순위에 초점을 맞추어, 지역/국가, 유형 및 용도별 분석을 종합적으로 제시하는 것을 목표로 합니다.

이 보고서는 2024년을 기준 연도, 2020년에서 2031년까지의 과거 데이터와 2031년까지의 예측 데이터를 포함하는 판매량(톤)과 매출액(백만 달러)으로 리조팀 시장 규모, 추정 및 예측을 제시했습니다. 정량적, 정성적 분석을 통해 독자들이 리소자임 관련 사업 전략 및 성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 자사 포지셔닝 분석, 정보에 입각한 사업적 판단을 할 수 있도록 도와드립니다.

시장 세분화

기업별

• Bioseutica
• Novozymes
• dsm-firmenich
• Bouwhuis Enthoven
• Chr. Hansen
• Calza Clemente
• Proquiga Biotech
• Zhejiang Aegis Biotech
• Greensnow Egg Products Development
• Jiangsu Kangde Egg
• Jiangsu Aige
• ECOT China
• Kewpie
• EPS S.P.A
• Anhui Rongda

유형별 부문

• 난백형
• 미생물형

용도별 부문

• 식품
• 의약품
• 사료

지역별

• 북미
  • 미국
  • 캐나다
• 아시아태평양
  • 중국
  • 일본
  • 한국
  • 동남아시아
  • 인도
  • 호주
  • 기타 아시아태평양
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 네덜란드
  • 북유럽 국가
  • 기타 유럽
• 라틴아메리카
  • 멕시코
  • 브라질
  • 기타 라틴아메리카
• 중동 및 아프리카
  • 튀르키예
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동 및 아프리카

영문목차

The global market for Lysozyme was estimated to be worth US$ 76.18 million in 2024 and is forecast to a readjusted size of US$ 92.99 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Lysozyme cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Lysozyme, also known as muramidase or N-acetylmuramide glycanohydrlase, is an alkaline enzyme that can hydrolyze mucopolysaccharides in bacteria. Lysozyme mainly breaks the B-1,4 glycosidic bond between N-acetylmuramic acid and N-acetylglucosamine in the cell wall, decomposing the insoluble mucopolysaccharide of the cell wall into soluble glycopeptides, causing cell wall rupture and bacterial dissolution. Lysozyme can also directly bind to negatively charged viral proteins and form complexes with DNA, RNA, and apoproteins to inactivate the virus. According to its different sources, it can be divided into egg white lysozyme and microbial lysozyme.

In terms of product types, egg white type occupies an important position,and the revenue share is expected to reach about 60% in 2031. The price gap between egg white type lysozyme and microbial type lysozyme is large, which is closely related to the activity of lysozyme.

Asia, Latin America and Europe are the main consumption areas of lysozyme. Latin America is the world's largest consumer market in 2024.

The global major manufacturers of Lysozyme include Bioseutica, Novozymes, Zhejiang Aegis Biotech, dsm-firmenich, and Greensnow Egg Products Development, etc. In terms of revenue, the global top three players account for over 70% market share in 2024.

This report aims to provide a comprehensive presentation of the global market for Lysozyme, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Lysozyme by region & country, by Type, and by Application.

The Lysozyme market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lysozyme.

Market Segmentation

By Company

• Bioseutica
• Novozymes
• dsm-firmenich
• Bouwhuis Enthoven
• Chr. Hansen
• Calza Clemente
• Proquiga Biotech
• Zhejiang Aegis Biotech
• Greensnow Egg Products Development
• Jiangsu Kangde Egg
• Jiangsu Aige
• ECOT China
• Kewpie
• EPS S.P.A
• Anhui Rongda

Segment by Type

• Egg White Type
• Microbial Type

Segment by Application

• Food
• Pharma
• Feed

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Lysozyme manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Lysozyme in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Lysozyme in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Lysozyme Product Introduction
• 1.2 Global Lysozyme Market Size Forecast
  • 1.2.1 Global Lysozyme Sales Value (2020-2031)
  • 1.2.2 Global Lysozyme Sales Volume (2020-2031)
  • 1.2.3 Global Lysozyme Sales Price (2020-2031)
• 1.3 Lysozyme Market Trends & Drivers
  • 1.3.1 Lysozyme Industry Trends
  • 1.3.2 Lysozyme Market Drivers & Opportunity
  • 1.3.3 Lysozyme Market Challenges
  • 1.3.4 Lysozyme Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Lysozyme Players Revenue Ranking (2024)
• 2.2 Global Lysozyme Revenue by Company (2020-2025)
• 2.3 Global Lysozyme Players Sales Volume Ranking (2024)
• 2.4 Global Lysozyme Sales Volume by Company Players (2020-2025)
• 2.5 Global Lysozyme Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Lysozyme Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Lysozyme Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Lysozyme
• 2.9 Lysozyme Market Competitive Analysis
  • 2.9.1 Lysozyme Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Lysozyme Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysozyme as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Egg White Type
  • 3.1.2 Microbial Type
• 3.2 Global Lysozyme Sales Value by Type
  • 3.2.1 Global Lysozyme Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Lysozyme Sales Value, by Type (2020-2031)
  • 3.2.3 Global Lysozyme Sales Value, by Type (%) (2020-2031)
• 3.3 Global Lysozyme Sales Volume by Type
  • 3.3.1 Global Lysozyme Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Lysozyme Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Lysozyme Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Lysozyme Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Food
  • 4.1.2 Pharma
  • 4.1.3 Feed
• 4.2 Global Lysozyme Sales Value by Application
  • 4.2.1 Global Lysozyme Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Lysozyme Sales Value, by Application (2020-2031)
  • 4.2.3 Global Lysozyme Sales Value, by Application (%) (2020-2031)
• 4.3 Global Lysozyme Sales Volume by Application
  • 4.3.1 Global Lysozyme Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Lysozyme Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Lysozyme Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Lysozyme Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Lysozyme Sales Value by Region
  • 5.1.1 Global Lysozyme Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Lysozyme Sales Value by Region (2020-2025)
  • 5.1.3 Global Lysozyme Sales Value by Region (2026-2031)
  • 5.1.4 Global Lysozyme Sales Value by Region (%), (2020-2031)
• 5.2 Global Lysozyme Sales Volume by Region
  • 5.2.1 Global Lysozyme Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Lysozyme Sales Volume by Region (2020-2025)
  • 5.2.3 Global Lysozyme Sales Volume by Region (2026-2031)
  • 5.2.4 Global Lysozyme Sales Volume by Region (%), (2020-2031)
• 5.3 Global Lysozyme Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Lysozyme Sales Value, 2020-2031
  • 5.4.2 North America Lysozyme Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Lysozyme Sales Value, 2020-2031
  • 5.5.2 Europe Lysozyme Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Lysozyme Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Lysozyme Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Lysozyme Sales Value, 2020-2031
  • 5.7.2 South America Lysozyme Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Lysozyme Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Lysozyme Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Lysozyme Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Lysozyme Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Lysozyme Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Lysozyme Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Lysozyme Sales Value, 2020-2031
  • 6.3.2 United States Lysozyme Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Lysozyme Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Lysozyme Sales Value, 2020-2031
  • 6.4.2 Europe Lysozyme Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Lysozyme Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Lysozyme Sales Value, 2020-2031
  • 6.5.2 China Lysozyme Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Lysozyme Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Lysozyme Sales Value, 2020-2031
  • 6.6.2 Japan Lysozyme Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Lysozyme Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Lysozyme Sales Value, 2020-2031
  • 6.7.2 South Korea Lysozyme Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Lysozyme Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Lysozyme Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Lysozyme Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Lysozyme Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Lysozyme Sales Value, 2020-2031
  • 6.9.2 India Lysozyme Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Lysozyme Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Bioseutica
  • 7.1.1 Bioseutica Company Information
  • 7.1.2 Bioseutica Introduction and Business Overview
  • 7.1.3 Bioseutica Lysozyme Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Bioseutica Lysozyme Product Offerings
  • 7.1.5 Bioseutica Recent Development
• 7.2 Novozymes
  • 7.2.1 Novozymes Company Information
  • 7.2.2 Novozymes Introduction and Business Overview
  • 7.2.3 Novozymes Lysozyme Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Novozymes Lysozyme Product Offerings
  • 7.2.5 Novozymes Recent Development
• 7.3 dsm-firmenich
  • 7.3.1 dsm-firmenich Company Information
  • 7.3.2 dsm-firmenich Introduction and Business Overview
  • 7.3.3 dsm-firmenich Lysozyme Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 dsm-firmenich Lysozyme Product Offerings
  • 7.3.5 dsm-firmenich Recent Development
• 7.4 Bouwhuis Enthoven
  • 7.4.1 Bouwhuis Enthoven Company Information
  • 7.4.2 Bouwhuis Enthoven Introduction and Business Overview
  • 7.4.3 Bouwhuis Enthoven Lysozyme Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Bouwhuis Enthoven Lysozyme Product Offerings
  • 7.4.5 Bouwhuis Enthoven Recent Development
• 7.5 Chr. Hansen
  • 7.5.1 Chr. Hansen Company Information
  • 7.5.2 Chr. Hansen Introduction and Business Overview
  • 7.5.3 Chr. Hansen Lysozyme Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Chr. Hansen Lysozyme Product Offerings
  • 7.5.5 Chr. Hansen Recent Development
• 7.6 Calza Clemente
  • 7.6.1 Calza Clemente Company Information
  • 7.6.2 Calza Clemente Introduction and Business Overview
  • 7.6.3 Calza Clemente Lysozyme Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Calza Clemente Lysozyme Product Offerings
  • 7.6.5 Calza Clemente Recent Development
• 7.7 Proquiga Biotech
  • 7.7.1 Proquiga Biotech Company Information
  • 7.7.2 Proquiga Biotech Introduction and Business Overview
  • 7.7.3 Proquiga Biotech Lysozyme Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Proquiga Biotech Lysozyme Product Offerings
  • 7.7.5 Proquiga Biotech Recent Development
• 7.8 Zhejiang Aegis Biotech
  • 7.8.1 Zhejiang Aegis Biotech Company Information
  • 7.8.2 Zhejiang Aegis Biotech Introduction and Business Overview
  • 7.8.3 Zhejiang Aegis Biotech Lysozyme Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Zhejiang Aegis Biotech Lysozyme Product Offerings
  • 7.8.5 Zhejiang Aegis Biotech Recent Development
• 7.9 Greensnow Egg Products Development
  • 7.9.1 Greensnow Egg Products Development Company Information
  • 7.9.2 Greensnow Egg Products Development Introduction and Business Overview
  • 7.9.3 Greensnow Egg Products Development Lysozyme Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Greensnow Egg Products Development Lysozyme Product Offerings
  • 7.9.5 Greensnow Egg Products Development Recent Development
• 7.10 Jiangsu Kangde Egg
  • 7.10.1 Jiangsu Kangde Egg Company Information
  • 7.10.2 Jiangsu Kangde Egg Introduction and Business Overview
  • 7.10.3 Jiangsu Kangde Egg Lysozyme Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Jiangsu Kangde Egg Lysozyme Product Offerings
  • 7.10.5 Jiangsu Kangde Egg Recent Development
• 7.11 Jiangsu Aige
  • 7.11.1 Jiangsu Aige Company Information
  • 7.11.2 Jiangsu Aige Introduction and Business Overview
  • 7.11.3 Jiangsu Aige Lysozyme Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Jiangsu Aige Lysozyme Product Offerings
  • 7.11.5 Jiangsu Aige Recent Development
• 7.12 ECOT China
  • 7.12.1 ECOT China Company Information
  • 7.12.2 ECOT China Introduction and Business Overview
  • 7.12.3 ECOT China Lysozyme Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 ECOT China Lysozyme Product Offerings
  • 7.12.5 ECOT China Recent Development
• 7.13 Kewpie
  • 7.13.1 Kewpie Company Information
  • 7.13.2 Kewpie Introduction and Business Overview
  • 7.13.3 Kewpie Lysozyme Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.13.4 Kewpie Lysozyme Product Offerings
  • 7.13.5 Kewpie Recent Development
• 7.14 EPS S.P.A
  • 7.14.1 EPS S.P.A Company Information
  • 7.14.2 EPS S.P.A Introduction and Business Overview
  • 7.14.3 EPS S.P.A Lysozyme Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.14.4 EPS S.P.A Lysozyme Product Offerings
  • 7.14.5 EPS S.P.A Recent Development
• 7.15 Anhui Rongda
  • 7.15.1 Anhui Rongda Company Information
  • 7.15.2 Anhui Rongda Introduction and Business Overview
  • 7.15.3 Anhui Rongda Lysozyme Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.15.4 Anhui Rongda Lysozyme Product Offerings
  • 7.15.5 Anhui Rongda Recent Development

8 Industry Chain Analysis

• 8.1 Lysozyme Industrial Chain
• 8.2 Lysozyme Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Lysozyme Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Lysozyme Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer